Skip to main content
SpringerLink
Log in

Polymorphisms in the pituitary growth hormone gene and its receptor associated with coronary artery disease in a predisposed cohort from India

  • Research Article
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

We investigated the promoter polymorphisms of the pituitary growth hormone gene (GH1) and exon 3 deletion polymorphism (GHRd3) in its receptor gene (GHR) in 299 angiographically proven patients with coronary artery disease (CAD) and 231 asymptomatic controls enrolled in the ongoing Indian Atherosclerosis Research Study. Real time PCR based analysis of the GHR variant showed significant association of the GHRd3 deletion allele with CAD (OR 0.48, 95% CI: 0.30–0.76, P = 0.0014) and a dominant model of inheritance (Akaike information criterion = 482). The deletion allele showed significant association with high plasma HDL-c levels (P = 0.001). Sequencing of the proximal promoter region of GH1 revealed 12 novel polymorphisms and a TAGA haplotype constituted by the functional SNPs rs2005171, rs11568828, rs2005172 and rs6171, that showed significant association with CAD alone (adjusted OR of 3.31 (95% CI = 1.33–8.29, P = 0.011) and in CAD patients with diabetes (P = 0.019). Mean standardized height was associated with three of the four haplotype-tagging SNPs in the cohort (P ≤ 0.03). Eleven of the 12 polymorphic promoter SNPs contributed to 14.7% of variation in height in females in the whole dataset (P = 0.029). CAD patients with history of stroke exhibited marginally significantly lower mean height as compared to rest of the cohort (P < 0.006). In conclusion, genetic polymorphisms in the GHR gene and its ligand, GH1, may modulate the risk of CAD in the Asian Indian population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abramson J. H. 2004 WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol. Perspect. Innov. 1, 6.

    Article  PubMed  Google Scholar 

  • Barker D. J. 1995 The fetal and infant origins of disease. Eur. J. Clin. Invest. 25, 457–463.

    Article  PubMed  CAS  Google Scholar 

  • Barrett J. C., Fry B., Maller J. and Daly M. J. 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265.

    Article  PubMed  CAS  Google Scholar 

  • Binder G., Trebar B., Baur F., Schweizer R. and Ranke M. B. 2008 Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Tumer syndrome. Clin. Endocrinol. 68, 567–572.

    Article  CAS  Google Scholar 

  • Blum W. F., Machinis K., Shavrikova E. P., Keller A., Stobbe H., Pfaeffle R. W. and Amselem S. 2006 The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor. J. Clin. Endocrinol. Metab. 91, 4171–4174.

    Article  PubMed  CAS  Google Scholar 

  • Bondanelli M., Ambrosio M. R., Onofri A., Bergonzoni A., Lavezzi S., Zatelli M. C. et al. 2006 Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. J. Clin. Endocrinol. Metab. 91, 3928–3934.

    Article  PubMed  CAS  Google Scholar 

  • Carrascosa A., Audi L., Esteban C., Fernandez-Cancio M., Andaluz P., Gussinye M. et al. 2008 Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH therapy in short small-for-gestational-age children. J. Clin. Endocrinol. Metab. 93, 147–153.

    Article  PubMed  CAS  Google Scholar 

  • Cittadini A., Cuocolo A., Merola B., Fazio S., Sabatini D., Nicolai E. et al. 1994 Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am. J. Physiol. 267, E219–E225.

    PubMed  CAS  Google Scholar 

  • Climent V. E., Pico A., Sogorb F., Aznar S., Lip G. Y. and Marin F. 2006 Growth hormone therapy and the heart. Am. J. Cardiol. 97, 1097–1102.

    Article  PubMed  CAS  Google Scholar 

  • Cohen L. E., Wondisford F. E. and Radovick S. 1996 Role of Pit-1 in the gene expression of growth hormone, prolactin, and thyrotropin. Endocrinol. Metab. Clin. North Am. 25, 523–540.

    Article  PubMed  CAS  Google Scholar 

  • Esteban C., Audi L., Carrascosa A., Fernandez-Cancio M., Perez-Arroyo A., Ulied A. et al. 2007 Human growth hormone (GH1) gene polymorphism map in a normal-statured adult population. Clin. Endocrinol. 66, 258–268.

    Article  CAS  Google Scholar 

  • Friedewald W. T., Levy R. I. and Fredrickson D. S. 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502.

    PubMed  CAS  Google Scholar 

  • Garcia-Aragon J., Lobie P. E., Muscat G. E., Gobius K. S., Norstedt G. and Waters M. J. 1992 Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development? Development 114, 869–876.

    PubMed  CAS  Google Scholar 

  • Genth-Zotz S., Zotz R., Geil S., Voigtlander T., Meyer J. and Darius H. 1999 Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation 99, 18–21.

    PubMed  CAS  Google Scholar 

  • Greenacre M. J. 1984 Theory and applications of correspondence analysis.Academic Press, London, UK.

    Google Scholar 

  • Horan M., Millar D. S., Hedderich J., Lewis G., Newsway V., Mo N., Fryklund L. et al. 2003 Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region. Hum. Mutat. 21, 408–423.

    Article  PubMed  CAS  Google Scholar 

  • Horan M., Newsway V., Yasmin N., Lewis M. D., Easter T. E., Rees D. A. et al. 2006 Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke. Hum. Genet. 119, 527–540.

    Article  PubMed  CAS  Google Scholar 

  • Hubbard T. J., Aken B. L., Beal K., Ballester B., Caccamo M., Chen Y. 2007 Nucleic Acids Res. 35 (Database issue), D610–D617.

    Article  PubMed  CAS  Google Scholar 

  • Indian Genome Variation Consortium 2008 Genetic landscape of the people of India: a canvas for disease gene exploration. J. Genet. 87, 3–18.

    Article  Google Scholar 

  • Jensen R. B., Vielwerth S., Larsen T., Greisen G., Leffers H. and Juul A. 2007 The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects. J. Clin. Endocrinol. Metab. 92, 2758–2763.

    Article  PubMed  CAS  Google Scholar 

  • Jimenez-Lara A. M. and Aranda A. 2000 Interaction of vitamin D and retinoid receptors on regulation of gene expression. Horm. Res. 54, 301–305.

    Article  PubMed  CAS  Google Scholar 

  • Johnson R., McNutt P., MacMahon S. and Robson R. 1997 Use of the Friedwald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin. Chem. 43, 2183–2184.

    PubMed  CAS  Google Scholar 

  • Jorge A. A., Marchisotti F. G., Montenegro L. R., Carvalho L. R., Mendonca B. B. and Arnhold I. J. 2006 Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J. Clin. Endocrinol.Metab. 91, 1076–1080.

    Article  PubMed  CAS  Google Scholar 

  • Ko J. M., Park J. Y. and Yoo H. W. 2009 Common exon 3 polymorphism of the GH receptor (GHR) gene and effect of GH therapy on growth in Korean children with idiopathic short stature (ISS). Clin. Endocrinol. 70, 82–87.

    Article  CAS  Google Scholar 

  • Kumar N. K. 2006 Bioethics activities in India. East Mediterr. Health J. 12suppl 1, S56–S65.

    PubMed  Google Scholar 

  • Langenberg C., Hardy R., Breeze E., Kuh D. and Wadsworth M. E. 2005 Influence of short stature on the change in pulse pressure, systolic and diastolic blood pressure from age 36 to 53 years: an analysis using multilevel models. Int. J. Epidemiol. 34, 905–913.

    Article  PubMed  Google Scholar 

  • Le Corvoisier P., Hittinger L., Chanson P., Montagne O., Macquin-Mavier I., Maison P. 2007 Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis. J. Clin. Endocrinol. Metab. 92, 180–185.

    Article  PubMed  Google Scholar 

  • McCarron P., Greenwood R., Ebrahim S., Elwood P. and Smith G. D. 2000 Adult height is inversely associated with ischaemic stroke. The Caerphilly and Speedwell collaborative studies. J. Epidemiol. Commun. Health 54, 239–240.

    Article  CAS  Google Scholar 

  • Millar D. S., Lewis M. D., Horan M., Newsway V., Rees D. A., Easter T. E. et al. 2008 Growth hormone (GH1) gene variation and the growth hormone receptor (GHR) exon 3 deletion polymorphism in a West-African population. Mol. Cell Endocrinol. 296, 18–25.

    Article  PubMed  CAS  Google Scholar 

  • Miller S. A., Dykes D. D. and Polesky H. F. 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.

    Article  PubMed  CAS  Google Scholar 

  • Minczykowski A., Gryczynska M., Ziemnicka K., Czepczynski R., Sowinski J. and Wysocki H. 2005 The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency. Growth Horm. IGF Res. 15, 156–164.

    Article  PubMed  CAS  Google Scholar 

  • Mullis P. E. 2005 Genetic control of growth. Eur. J. Endocrinol. 152, 11–31.

    Article  PubMed  CAS  Google Scholar 

  • Pfaffl M. W. A 2001 New mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, 2002–2007.

    Article  Google Scholar 

  • Pfeifer M., Verhovec R. and Zizek B. 1999a Growth hormone (GH) and atherosclerosis: changes in morphology and function of major arteries during GH treatment. Growth Horm. IGF Res. 9, suppl. 25–30.

    Article  PubMed  Google Scholar 

  • Pfeifer M., Verhovec R., Zizek B., Prezelj J., Poredos P. and Clayton R. N. 1999b Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J. Clin. Endocrinol. Metab. 84, 453–457.

    Article  PubMed  CAS  Google Scholar 

  • Reed D. M., Resch J. A., Hayashi T., MacLean C. and Yano K. A. 1988 Prospective study of cerebral artery atherosclerosis. Stroke 19, 820–825.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez S., Gaunt T. R. and Day I. N. 2007 Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease. Hum. Genet. 122, 1–21.

    Article  PubMed  CAS  Google Scholar 

  • Sole X., Guino E., Valls J., Iniesta R. and Moreno V. 2006 SNPStats: a web tool for the analysis of association studies. Bioinformatics 22, 1928–1929.

    Article  PubMed  CAS  Google Scholar 

  • Song Y. M., Smith G. D. and Sung J. 2003 Adult height and causespecific mortality: a large prospective study of South Korean men. Am. J. Epidemiol. 158, 479–485.

    Article  PubMed  Google Scholar 

  • Sorensen K., Aksglaede L., Munch-Andersen T., Aachmann-Andersen N. J., Leffers H., Helge J. W. et al. 2009 Impact of the growth hormone receptor exon 3 deletion gene polymorphism on glucose metabolism, lipids, and insulin-like growth factor-I levels during puberty. J. Clin. Endocrinol. Metab. 94, 2966–2969.

    Article  PubMed  Google Scholar 

  • Stein C. E., Fall C. H., Kumaran K., Osmond C., Cox V. and Barker D. J. 1996 Fetal growth and coronary heart disease in south India. Lancet 348, 1269–1273.

    Article  PubMed  CAS  Google Scholar 

  • Strawbridge R. J., Karvestedt L., Li C., Efendic S., Ostenson C. G., Gu H. F. and Brismar K. 2007 GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder. Growth Horm. IGF Res. 17, 392–398.

    Article  PubMed  CAS  Google Scholar 

  • Suen C. S., Yen P. M. and Chin W. W. 1994 In vitro transcriptional studies of the roles of the thyroid hormone (T3) response elements and minimal promoters in T3-stimulated gene transcription. J. Biol. Chem. 269, 1314–1322.

    PubMed  CAS  Google Scholar 

  • Tauber M., Ester W., Auriol F., Molinas C., Fauvel J., Caliebe J. et al. 2007 GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism. Clin. Endocrinol. 67, 457–461.

    Article  CAS  Google Scholar 

  • van der Klaauw A. A., van der Straaten T., Baak-Pablo R., Biermasz N. R., Guchelaar H. J., Pereira A. M. et al. 2008 Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults. J. Clin. Endocrinol. Metab. 93, 2828–2834.

    Article  PubMed  Google Scholar 

  • Vickers M. H., Ikenasio B. A. and Breier B. H. 2002 Adult growth hormone treatment reduces hypertension and obesity induced by an adverse prenatal environment. J. Endocrinol. 175, 615–623.

    Article  PubMed  CAS  Google Scholar 

  • World Medical Association declaration of Helsinki 1997 Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277, 925–926.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mary and Garry Weston Functional Genomics Unit, Thrombosis Research Institute India, 258/A, Bommasandra Industrial Area, Bangalore, 560 099, India

    Arindam Maitra, Jayashree Shanker, Debabrata Dash, Prathima R. Sannappa, Pratibha Siwach & Vijay V. Kakkar

  2. Elizabeth and Emmanuel Kaye Bioinformatics and Statistics Unit, Thrombosis Research Institute India, 258/A, Bommasandra Industrial Area, Bangalore, 560 099, India

    Shibu John & H. Sridhara

  3. Tata Proteomics and Coagulation Unit, Thrombosis Research Institute India, 258/A, Bommasandra Industrial Area, Bangalore, 560 099, India

    Veena S. Rao

  4. Thrombosis Research Institute-London, Emmanuel Kaye Building, Manresa Road, Chelsea, SW3 6LR, London, UK

    Vijay V. Kakkar

Authors
  1. Arindam Maitra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jayashree Shanker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Debabrata Dash
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prathima R. Sannappa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shibu John
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pratibha Siwach
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Veena S. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Sridhara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Vijay V. Kakkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Arindam Maitra or Jayashree Shanker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maitra, A., Shanker, J., Dash, D. et al. Polymorphisms in the pituitary growth hormone gene and its receptor associated with coronary artery disease in a predisposed cohort from India. J Genet 89, 437 (2010). https://doi.org/10.1007/s12041-010-0062-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12041-010-0062-6

Keywords

Search

Navigation